ResMed Total Liabilities and Share Holders Equity 2010-2024 | RMD
ResMed total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- ResMed total liabilities and share holders equity for the quarter ending September 30, 2024 was $7.222B, a 7.15% increase year-over-year.
- ResMed total liabilities and share holders equity for 2024 was $6.872B, a 1.79% increase from 2023.
- ResMed total liabilities and share holders equity for 2023 was $6.752B, a 32.49% increase from 2022.
- ResMed total liabilities and share holders equity for 2022 was $5.096B, a 7.78% increase from 2021.
| ResMed Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $6,872 |
| 2023 | $6,752 |
| 2022 | $5,096 |
| 2021 | $4,728 |
| 2020 | $4,587 |
| 2019 | $4,108 |
| 2018 | $3,064 |
| 2017 | $3,468 |
| 2016 | $3,257 |
| 2015 | $2,182 |
| 2014 | $2,361 |
| 2013 | $2,211 |
| 2012 | $2,138 |
| 2011 | $2,069 |
| 2010 | $1,626 |
| 2009 | $1,508 |
| ResMed Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $7,222 |
| 2024-06-30 | $6,872 |
| 2024-03-31 | $6,815 |
| 2023-12-31 | $6,905 |
| 2023-09-30 | $6,741 |
| 2023-06-30 | $6,752 |
| 2023-03-31 | $6,714 |
| 2022-12-31 | $6,676 |
| 2022-09-30 | $5,178 |
| 2022-06-30 | $5,096 |
| 2022-03-31 | $4,905 |
| 2021-12-31 | $4,735 |
| 2021-09-30 | $4,729 |
| 2021-06-30 | $4,728 |
| 2021-03-31 | $4,586 |
| 2020-12-31 | $4,573 |
| 2020-09-30 | $4,621 |
| 2020-06-30 | $4,587 |
| 2020-03-31 | $4,511 |
| 2019-12-31 | $4,354 |
| 2019-09-30 | $4,155 |
| 2019-06-30 | $4,108 |
| 2019-03-31 | $4,099 |
| 2018-12-31 | $3,860 |
| 2018-09-30 | $3,068 |
| 2018-06-30 | $3,064 |
| 2018-03-31 | $3,534 |
| 2017-12-31 | $3,564 |
| 2017-09-30 | $3,490 |
| 2017-06-30 | $3,468 |
| 2017-03-31 | $3,423 |
| 2016-12-31 | $3,323 |
| 2016-09-30 | $3,322 |
| 2016-06-30 | $3,257 |
| 2016-03-31 | $2,445 |
| 2015-12-31 | $2,239 |
| 2015-09-30 | $2,255 |
| 2015-06-30 | $2,182 |
| 2015-03-31 | $2,278 |
| 2014-12-31 | $2,327 |
| 2014-09-30 | $2,309 |
| 2014-06-30 | $2,361 |
| 2014-03-31 | $2,365 |
| 2013-12-31 | $2,346 |
| 2013-09-30 | $2,335 |
| 2013-06-30 | $2,211 |
| 2013-03-31 | $2,375 |
| 2012-12-31 | $2,330 |
| 2012-09-30 | $2,245 |
| 2012-06-30 | $2,138 |
| 2012-03-31 | $2,129 |
| 2011-12-31 | $2,041 |
| 2011-09-30 | $1,935 |
| 2011-06-30 | $2,069 |
| 2011-03-31 | $1,962 |
| 2010-12-31 | $1,884 |
| 2010-09-30 | $1,792 |
| 2010-06-30 | $1,626 |
| 2010-03-31 | $1,713 |
| 2009-12-31 | $1,621 |
| 2009-09-30 | $1,620 |
| 2009-06-30 | $1,508 |
| 2009-03-31 | $1,326 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.048B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $202.220B | 25.79 |
| Stryker (SYK) | United States | $143.322B | 32.30 |
| Boston Scientific (BSX) | United States | $130.065B | 37.39 |
| Medtronic (MDT) | Ireland | $112.498B | 16.74 |
| EssilorLuxottica (ESLOY) | France | $111.686B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.423B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.501B | 28.26 |
| GE HealthCare Technologies (GEHC) | United States | $39.264B | 20.36 |
| Terumo (TRUMY) | Japan | $29.575B | 41.77 |
| Koninklijke Philips (PHG) | Netherlands | $25.012B | 19.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.536B | 13.71 |
| Insulet (PODD) | United States | $18.791B | 74.86 |
| Baxter (BAX) | United States | $17.673B | 11.51 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.619B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.338B | 35.13 |
| BellRing Brands (BRBR) | United States | $9.136B | 38.63 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.084B | 14.14 |
| Haemonetics (HAE) | United States | $4.474B | 21.43 |
| TG Therapeutics (TGTX) | United States | $4.460B | 0.00 |
| ICU Medical (ICUI) | United States | $4.318B | 41.21 |
| Prestige Consumer Healthcare (PBH) | United States | $3.983B | 19.75 |
| Perrigo (PRGO) | Ireland | $3.596B | 10.59 |
| Neogen (NEOG) | United States | $3.517B | 40.57 |
| Envista Holdings (NVST) | United States | $3.509B | 26.14 |
| Agios Pharmaceuticals (AGIO) | United States | $3.368B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $3.041B | 19.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.942B | 18.94 |
| LeMaitre Vascular (LMAT) | United States | $2.342B | 56.97 |
| Warby Parker (WRBY) | United States | $1.964B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.888B | 33.04 |
| AtriCure (ATRC) | United States | $1.826B | 0.00 |
| InMode (INMD) | Israel | $1.630B | 9.80 |
| Curaleaf Holdings (CURLF) | Canada | $1.384B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.357B | 9.70 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.280B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.206B | 0.00 |
| Owens & Minor (OMI) | United States | $0.995B | 7.77 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 17.04 |
| CeriBell (CBLL) | United States | $0.962B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.906B | 30.29 |
| Capricor Therapeutics (CAPR) | United States | $0.895B | 0.00 |
| Evolus (EOLS) | United States | $0.866B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.691B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.605B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.582B | 17.56 |
| Quanterix (QTRX) | United States | $0.580B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 0.00 |
| Valneva SE (VALN) | France | $0.426B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
| ZimVie (ZIMV) | United States | $0.393B | 33.12 |
| Viemed Healthcare (VMD) | United States | $0.353B | 33.59 |
| Cerus (CERS) | United States | $0.331B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.320B | 21.45 |
| Sanara MedTech (SMTI) | United States | $0.308B | 0.00 |
| Biote (BTMD) | United States | $0.301B | 13.90 |
| Zynex (ZYXI) | United States | $0.287B | 60.07 |
| Jin Medical (ZJYL) | China | $0.284B | 0.00 |
| MacroGenics (MGNX) | United States | $0.273B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.269B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 0.00 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.90 |
| High Tide (HITI) | Canada | $0.221B | 91.67 |
| Brainsway (BWAY) | Israel | $0.181B | 217.20 |
| Organigram Holdings (OGI) | Canada | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.151B | 20.39 |
| Rockwell Medical (RMTI) | United States | $0.137B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.116B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.111B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 9.82 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.10 |
| Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.079B | 2.67 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.20 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |